About
Professional SummaryDr. Abdel-Moneim Mahmoud Ali Osman holds a position of Professor at Cancer Institute, Cairo University and Deputed to the College of Medicine, King Abdel-Aziz University. He has completed his Post Doctoral Fellow in Cancer Research from University of Amsterdam, The Netherland, and PhD Pharmacology in College of Medicine, University of Amsterdam, Holland in 1985. He has published 79 research articles in journals contributed as author/co-author. He also completed 6 projects as Principal Investigator. He successfully supervised 25 Masters and 17 PhD thesis.
Education
Academic Background-
PostDoc Fellow University of Amsterdam, The Netherlands Cancer Research | Completed: 1986
Publications (86)
Selected Scholarly Contributions
Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
2019
Cardioprotective effect of marine astaxanthin on doxorubicin-induced cardiotoxicity in normal rats.
2019
Enhancement of doxorubicin cytotoxicity by verapamil in human breast cancer cells.
2019
Dimethyl sulfoxide potentiates the anticancer activity of cisplatin against the growth of lung cancer cells.
2019
Chemosensitizing effects of marine astaxanthin on the anti-cancer activity of doxorubicin in tumor bearing mice.
2019
Enhancement of efficacy and reduced toxicity of cisplatin through Self Nanoemulsifying Drug Delivery System (SNEDDS).
2017
Benefits of medication antidote signals for the detection of potential adverse drug reactions over contemporary methods of pharmacovigilance in hospitalized children.
2017
The chemopreventive role of aged garlic extract against chemically induced tongue carcinogenesis.
2016
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.
2016
Dibutyl phthalate induces oxidative stress and impairs spermatogenesis in adult rats.
2016
Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia.
2015
Dibutyl phthalate induces oxidative stress and impairs spermatogenesis in adult rat.
2015
Modulatory role of resveratrol on cytotoxic activity of cisplatin, sensitization and modification of cisplatin resistance in colorectal cancer cells.
2015
Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.
2014
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol.
2014
Acylated pregnane glycosides from Caralluma quadrangular.
2013
Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin-treated animals.
2013
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.
2012
In vitro cytotoxic screening of selected Saudi medicinal plants.
2012
Mechanisms of cardioprotective effect of aged garlic extract against doxorubicin-induced cardiotoxicity.
2012
Tumor lung cancer model for assessing anti-neoplastic effect of pmf in rodents: Histopathological study.
2011
Cytotoxic effect of dexamethasone restricted tononcycling, early G1 phase of melanoma cells.
2011
Potential mechanism for the effects of dexamethasoneon growth of human melanoma cells in vitro.
2010
Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats.
2010
Potential modulatory effect of selenium on the antitumor activity and toxicity of doxorubicin in tumor-bearing mice.
2009
Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
2009
Cytotoxic activity of bioactive fractions from PM701.
2009
Effect of protein depletion on host and tumor response to paclitaxel in experimental animals.
2009
Reversal of doxorubicin resistance by adenovirus-mediated transfer of cyclooxygenase-2 antisense in multidrug-resistant MCF-7 cells.
2007
Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm.
2006
Modulation of epirubicin cytotoxicity by tamoxifen in human breast cell lines.
2005
Prophylactic effect of tamoxifen against induction of mammary Carcinoma.
2004
Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
2004
New aspects in probucol cardioprotection against doxorubicin induced cardiotoxicity.
2003
Probucol and liver efficiency during hepatocarcinogenesis.
2001
Plasma Endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy.
2001
Plasma endothelin (ET-1) as a marker for doxorubicin-induced cardiotoxicity in egyptian patients.
2000
Modulation by verapamil of doxorubicin induced expression of multidrug resistance gene (mdr-1/P-glycoprotein) in murine tumour cells.
2000
Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid β-oxidation in isolated heart mitochondria.
2000
The protective effect of methimazole against cisplatin-induced nephrotoxicity.
2000
The protective effect of methimazole against cisplatin-induced chromosomal abberrations.
1999
Potential promise of using L-carnitine and Coenzyme Q10 as protective agents against Cisplatin-induced nephrotoxicity.
1999
Different modalities of methotrexate therapy in acute childhood lymphoblastic leukemia.
1999
Reversal of doxorubicin-induced cardiac metabolic damage by l-carnitine.
1999
Verapamil enhancement of the cytotoxic and cell cycle perturbation of doxorubicin in Ehrlich ascites carcinoma cells in vivo.
1998
Role of I131, MIBG assessment of neuroblastoma in children at NCI, Egypt.
1998
Verapamil enhancement of antitumour effect of cisdiamminodichloroplatin(II) in mouse bearing ehrlich ascites carcinoma cells.
1996
Effect of hyperthermia on the action of methotrexate against the growth of Ehrlich ascites carcinoma cells.
1996
Diltiazem potentiation of doxorubicin cytotoxicity and cellular uptake in Ehrlich ascites carcinoma cells.
1995
Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats.
1995
Evaluation of the protective role of thiola and WR-2721 against biological effect of radiation.
1994
Pharmacokinetic profile of methotrexate and 5-flurouracil in normal and bilharzial infested mice.
1994
Enhancement of doxorubicin-induced cytotoxicity by hyperthermia in Ehrlich ascites cells.
1994
Protective effect of desferrioxamine against doxorubicin-induced lethality and nephrotoxicity in mice.
1994
The oncolytic activity and effect on bone marrow cellular elements of methotrexate-cinnarine and mitomycin C-verapamil combinations EAC-bearing mice.
1993
Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma.
1993
Effect of desferrioxamine on doxorubicin-induced cardiotoxicity and haematotoxicity in mice.
1993
Effect of desferrioxamine on the hepatotoxicity of adriamycin in normal mice.
1993
Potentiation of doxorubicin cytotoxicity by the calcium channel blocker verapamil in Ehrlich Ascites cells.
1993
Protection and potentiation of methanesulfonate cytotoxicity by WR 2721 and Thiola.
1993
Ca+2 antagonist enhance the cytotoxicity of anticancer agent.The effect of verapamil and cinnerizine on cellular transport of (14 C) mitomycin C and (3 H) methotrexate.
1993
Experimental study to improve the therapeutic efficacy of cisplatin.
1993
Distribution and toxicity of 5-flurouracil after intraperitoneal and anal submucosal adminstration.
1992
Prevention of doxorubicin-induced myocardial haematological toxicity in rats by iron chelator desferrioxamine.
1992
Effect of methotrexate and adrenaline on the rate 3H-thymidine incorporation protein and mitotic index of rabbit epithelium of platine mucosa.
1991
Kinetics of dexamethasone-binding in leukemic cells in presence and absence of meta-iodobenzylguanidine (MIBG) and nicotinamide.
1991
Modulation of dexamethasone effect in butyrate-treated melanoma cells.
1991
Studies on drug metabolizing enzyme activity levels in liver of normal and Schistosomal infected mice.
1990
Regioselective synthesis and antitumour activity at 8-chloro-5-(P-N-Substituted sulfomoylphenyl)-aminobenzo (b)(1,8) naphthyridine.
1990
Improving effect of the cytotoxic drug methotrexate with the non-narcotic analgesic lysine acetyl salicylic acid.
1990
The possible beneficial effect of cancer treatment with methotrexate in combination with the narcotic analgesic butorphenol tartarate.
1990
Reactions with purine derivative. Synthesis of arylamino purines of antitumour effect.
1990
The influence of total intravenous anaesthesia with propofol on neonata status in elective Caesarean section, a comparative study with conventional anaesthesia.
1990
Synthesis and structure of purine dervivative as antitumour effect.
1989
Reaction of Purines derivatives with phosphorus pentaoxide and triethylamine and their antitumour effect.
1989
Potentiation of therapeutic effect of methanesulphonate and protection against its organ cytotoxicity by vitamin C in Ehrlich ascites carcinoma bearing mice.
1989
Pharmacokinetics of etanidazole (SR-2508) in bladder and cervical cancer.Evidence of diffusion from urine.
1988
Interaction of cisplatin with some common analgesics in vitro and in vivo study on the oncolytic activity against EAC.
1988
Effective antineoplastic therapy consisting of cisplatin and analgesics.
1988
Effect of L. Dopa on the growth of human melanoma cells in vitro.
1987
Glucocorticoid effect on melphalan cytotoxicity, cell cycle position,cell size and (3H) uridine incorporation in one among three human melanoma cell lines.
1987
Effect of melphalan on proliferation and cell cycle of human melanoma cells in vitro.
1987
Effect of ascorbic acid and melphalan on the growth of human melanoma cells.
1986
Glucocorticoid receptors and cell cycle progression in human melanoma cell lines.
1985
Comparative biopharmacological study on two related anticancer methanesulfonate of aminoglycols.
1979
Effect of two anticancer methanesulfonate of aminoglycols on some liver phosphatases in normal, bilharzial and tumour-bearing mice.
1977